Literature DB >> 2050757

Decreases in regional cerebral blood flow with normal aging.

A J Martin1, K J Friston, J G Colebatch, R S Frackowiak.   

Abstract

Positron emission tomographic (PET) images of regional cerebral blood flow (rCBF) from 30 normal, resting volunteers aged 30 to 85 years were analysed to identify areas where rCBF fell with age. Images were anatomically normalised, and a pixel-by-pixel linear regression was performed to remove differences in global CBF between subjects. Pixels at which rCBF then showed a significant (p less than 0.01) negative correlation with age were identified. They were displayed as a statistical parametric map (SPM) of correlations. We demonstrate an age-related decrease in adjusted rCBF in the cingulate, parahippocampal, superior temporal, medial frontal, and posterior parietal cortices bilaterally, and in the left insular and left posterior prefrontal cortices (omnibus significance, chi 2 = 2,291, p less than 0.0001, df = 1). Decreases in rCBF suggest a regionally specific loss of cerebral function with age. The affected areas were all limbic, or association, cortices. Therefore, these decreases may constitute the cerebral substrate of the cognitive changes that occur during normal aging.

Entities:  

Mesh:

Year:  1991        PMID: 2050757     DOI: 10.1038/jcbfm.1991.121

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  103 in total

Review 1.  Effects of medications on cerebral blood flow in late-life depression.

Authors:  Mitchell S Nobler; Kristian R Olvet; Harold A Sackeim
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

2.  Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics.

Authors:  Alan H Lockwood; Karin Weissenborn; Martin Bokemeyer; U Tietge; Wolfgang Burchert
Journal:  Metab Brain Dis       Date:  2002-03       Impact factor: 3.584

3.  Genetics and visual attention: selective deficits in healthy adult carriers of the epsilon 4 allele of the apolipoprotein E gene.

Authors:  P M Greenwood; T Sunderland; J L Friz; R Parasuraman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

4.  Diagnosis of suspected Alzheimer's disease is improved by automated analysis of regional cerebral blood flow.

Authors:  Bich-Ngoc-Thanh Tang; Satoshi Minoshima; Jean George; Annie Robert; Christian Swine; Patrice Laloux; Thierry Vander Borght
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-01       Impact factor: 9.236

5.  The scaling of spatial attention in visual search and its modification in healthy aging.

Authors:  P M Greenwood; Raja Parasuraman
Journal:  Percept Psychophys       Date:  2004-01

Review 6.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

7.  Brain energy metabolism and blood flow differences in healthy aging.

Authors:  Joel Aanerud; Per Borghammer; M Mallar Chakravarty; Kim Vang; Anders B Rodell; Kristjana Y Jónsdottir; Arne Møller; Mahmoud Ashkanian; Manouchehr S Vafaee; Peter Iversen; Peter Johannsen; Albert Gjedde
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-29       Impact factor: 6.200

8.  Neurometabolic coupling in the lateral geniculate nucleus changes with extended age.

Authors:  Baowang Li; Ralph D Freeman
Journal:  J Neurophysiol       Date:  2010-05-12       Impact factor: 2.714

9.  Separating function from structure in perfusion imaging of the aging brain.

Authors:  Iris Asllani; Christian Habeck; Ajna Borogovac; Truman R Brown; Adam M Brickman; Yaakov Stern
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

10.  Structural Correlation-based Outlier Rejection (SCORE) algorithm for arterial spin labeling time series.

Authors:  Sudipto Dolui; Ze Wang; Russell T Shinohara; David A Wolk; John A Detre
Journal:  J Magn Reson Imaging       Date:  2016-08-29       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.